Crohn's Disease and Colitis Trial, Recruiting NCT06742385 Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06742385
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease (CD) or ulcerative colitis (UC), confirmed by a doctor
  • You are 18 years old or older
  • Your inflammatory bowel disease (IBD) is currently active enough that your doctor needs to change your treatment — for example, starting a new medication, adjusting your dose, or adding another medicine (including steroids, aminosalicylates, immunosuppressants, or biologic therapies)
  • You are willing and able to use a smartphone app called SEMEIA to share information about your health
  • You agree to take part in the study for 12 months

Who may not be able to join:

  • You are unable to use a smartphone or email
  • You are under 18 years old
  • You are expected to have bowel surgery within the next 3 months
  • You are pregnant at the start of the study
  • You have had certain past bowel surgeries, such as removal of most or all of the colon, a stoma (bowel opening through the abdomen), or large portions of the intestine removed that have caused lasting diarrhoea or short bowel syndrome
  • You have had recent bowel surgery involving the small intestine in the last 6 months
  • You have another serious physical or mental health condition that is not well controlled
  • You are currently taking part in another clinical trial that involves an experimental treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 33 (0) 9 72 57 61 60

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Registry
ClinicalTrials.gov
Start date
18 September 2025
Est. completion
18 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of cumulative time spent in symptomatic remission within 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov